Increased plasma IL-17F levels in rheumatoid arthritis patients are responsive to methotrexate, anti-TNF, and T cell costimulatory modulation.
about
Decreased Frequency of IL-17F rs763780 Site Allele G is Associated With Genetic Susceptibility to Immune Thrombocytopenia in a Chinese Population.Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.The IL-23-IL-17 axis in inflammatory arthritis.CTLA-4 blockade in the treatment of rheumatoid arthritis: an update.Elevated autoantibodies against interleukin-17F correlate with disease activity in patients with early rheumatoid arthritis.Characterization of IL-17AA and IL-17FF in rheumatoid arthritis and multiple sclerosis.
P2860
Increased plasma IL-17F levels in rheumatoid arthritis patients are responsive to methotrexate, anti-TNF, and T cell costimulatory modulation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased plasma IL-17F levels ...... cell costimulatory modulation.
@en
Increased plasma IL-17F levels ...... cell costimulatory modulation.
@nl
type
label
Increased plasma IL-17F levels ...... cell costimulatory modulation.
@en
Increased plasma IL-17F levels ...... cell costimulatory modulation.
@nl
prefLabel
Increased plasma IL-17F levels ...... cell costimulatory modulation.
@en
Increased plasma IL-17F levels ...... cell costimulatory modulation.
@nl
P2093
P2860
P1433
P1476
Increased plasma IL-17F levels ...... cell costimulatory modulation.
@en
P2093
Jeffrey D Greenberg
Manish Jain
Michael Lock
Quynh A Lu
Renita Ramirez
Vika Furer
P2860
P2888
P304
P356
10.1007/S10753-014-0020-1
P577
2015-02-01T00:00:00Z